Anteris Technologies
Jennifer Englund serves as the Senior Vice President of Clinical & Regulatory Affairs at Anteris Technologies since June 2025. Previously, Jennifer held the position of Senior Vice President of Global Clinical Affairs at CVRx from May 2024 to February 2025, and served as Senior Vice President of Scientific Affairs and Vice President of Clinical Regulatory Affairs at Monteris Medical from February 2019 to December 2023. Other notable roles include Vice President of Clinical Regulatory & Quality at POPS! Diabetes Care, Inc., and Vice President of Clinical and Regulatory Affairs at Mardil Medical. Earlier in the career, Jennifer held positions at Catheter Robotics, Inc., Symbios Clinical, Coloplast, and Medtronic, contributing to various aspects of clinical and regulatory operations. Jennifer's educational background includes a degree from the University of Minnesota Duluth, completed in 1996.
This person is not in any teams
This person is not in any offices
Anteris Technologies
1 followers
Anteris Technologies is a structural heart company focused on developing innovative solutions to the biggest challenges facing aortic stenosis patients and their physicians. Our DurAVR™ Transcatheter Heart Valve (THV) System is designed for younger patients who need a heart valve that will last their lifetime. DurAVR™ THV is a unique, single-piece valve and its first-in-class biomimetic design replicates the normal blood flow of a healthy human aortic valve. | $AVR | ASX: AVR | #DurAVR #ADAPT #structuralheart #TAVR #TAVI #cardiology